Author: Muhammad Saqlain; Muhammad Muddasir Munir; Saif Ur Rehman; Aqsa Gulzar; Sahar Naz; Zaheer Ahmed; Azhar Hussain Tahir; Muhammad Mashhood
Title: Knowledge, attitude, practice and perceived barriers among healthcare professionals regarding COVID-19: A Cross-sectional survey from Pakistan Document date: 2020_4_17
ID: 7rvv2kzk_3
Snippet: COVID-19 transmits from person to person by droplets when an infected person sneezes and by direct contact and virus has an incubation period of 4-14 days [8] . Elderly and patients who suffered with chronic medical conditions like diabetes and cardiovascular diseases are more likely to get severe infection [8] . The main manifestations of COVID-19 are fever, dry cough, dyspnea, myalgia, fatigue, hypolymphaemia, and radiographic evidence of pneum.....
Document: COVID-19 transmits from person to person by droplets when an infected person sneezes and by direct contact and virus has an incubation period of 4-14 days [8] . Elderly and patients who suffered with chronic medical conditions like diabetes and cardiovascular diseases are more likely to get severe infection [8] . The main manifestations of COVID-19 are fever, dry cough, dyspnea, myalgia, fatigue, hypolymphaemia, and radiographic evidence of pneumonia [1, 9] . Presently, no antiviral therapy or vaccine is explicitly recommended for COVID-19 and implementation of preventive measures to control COVID-19 is the mainstay critical intervention [10] . Amidst to current pandemic, WHO has issued several guidelines and also started online courses and training sessions to raise awareness and preparedness regarding prevention and control of . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- antiviral therapy and cardiovascular disease diabetes: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy and cc international license: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy and control prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- antiviral therapy and current pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- antiviral therapy and direct contact: 1, 2, 3, 4, 5, 6
- antiviral therapy and dry cough: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- antiviral therapy and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- antiviral therapy and infected person: 1
- antiviral therapy and international license: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy and main manifestation: 1
- antiviral therapy and medical condition: 1, 2, 3, 4
- antiviral therapy and pneumonia radiographic evidence: 1, 2, 3
- antiviral therapy and radiographic evidence: 1, 2, 3, 4
- antiviral therapy and severe infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- antiviral therapy and vaccine antiviral therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- antiviral therapy and virus direct contact: 1
- cardiovascular disease and cc international license: 1, 2, 3, 4, 5, 6, 7
- cardiovascular disease and control prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- cardiovascular disease and critical intervention: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date